Saint Vincent and the Grenadines
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 2.6 (2.5–2.6)
Mortality (HIV+TB only) <0.01 (<0.01–0.011) 2.5 (0.03–9.9)
Prevalence  (includes HIV+TB) 0.027 (<0.01–0.061) 24 (5.6–56)
Incidence  (includes HIV+TB) 0.026 (0.022–0.031) 24 (20–29)
Incidence (HIV+TB only) <0.01 (<0.01–0.017) 8.7 (3.9–15)
Case detection, all forms (%) 110 (96–140)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 27 (90) Relapse 0 (0)
Smear-negative 3 (10) Treatment after failure 0 (0)
Smear-unknown / not done 0 (0) Treatment after default 4 (100)
Extrapulmonary 0 (0) Other 0 (0)
Other 0 (0)      
Total new 30   Total retreatment 4  
           
Other (history unknown) 0        
Total new and relapse 30   Total cases notified 34  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.4    
Age < 15 0 0 0
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 56   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 25  
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status 31 (91)
HIV-positive TB patients 9 (29)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 6 (67)
HIV-positive TB patients on antiretroviral therapy (ART) 6 (67)
HIV-positive people screened for TB 58  
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.4–3.1) 14 (4.6–23)
MDR-TB cases among notified pulmonary
TB cases
1 (0–1) 1 (0–1)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 2 (7%) 0 (0%) 2
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     0
Financing TB control 2013
National TB programme budget (US$ millions)  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data